Table 3. The correlation analysis.

*median value 13.56 mmol/L, ** median value 6.80 %, ***median value 70.6 60 mL/min/1.73 m²

Patient group (No)	Spearman correlation (p)
	HCY/UA	HCY/eGFR	UA/eGFR	UA/HbA1c
All patients (52)	rho=0.298 p=0.038	rho=-0.338 p=0.023	rho=-0.525 p<0.001	rho=-0.322 p=0.024
Age (years)
<55 (10)	p=0.139	p=0.966	rho=-0.565/ p=0.356	p=0.460
55-65 (23)	p=0.480	p=0.145	rho=-0.799/ p=0.009	p=0.519
>65 (19)	p=0.062	p=0.383	p<0.001	p=0.180
Gender
Males (40)	p=0.101	p=0.212	rho=-0.556/ p=0.001	p=0.090
Females (12)	p=0.110	p=0.310	rho=-0.685/ p=0.029	p=0.055
Smoking
Yes (24)	p=0.345	p=0.192	p=0.078	p=0.790
No (28)	p=0.715	p=0.220	rho=-0.644/ p=0.002	p=0.376
Hypertension
Yes (30)	p=0.216	p=0.140	rho=-0.404/ p=0.030	p=0.353
No (22)	p=0.260	p=0.943	p=0.655	p=0.186
Homocysteine
<median value* (26)	p=0.300	p=0.816	p=0.134	p=0.083
>median value* (26)	p=0.737	p=0.113	rho=-0.672/ p=0.001	p=0.265
Uric acid
<272.0 mmol/L (18)	p=0.713	p=0.899	p=0.703	p=0.271
272.0-356.0 µmol/L (17)	p=0.077	rho=-0.574/p=0.550	rho=-0.509/ p=1.00	p=0.795
>356.0 mmol/L (17)	p=0.602	p=0.020	p=0.044	p=0.473
HbA1c
<median value** (26)	p=0.842	p=0.099	p=0.173	rho=0453/ p=0.026
>median value** (26)	p=0.134	p=0.416	p=0.094	p=0.674
GFR
<median value***(26)	rho=0.464/ p=0.022	rho=-0.463/p=0.023	rho=0.513/ p=0.010	p=0.453
>median value***(26)	p=0.819	p=0.186	p=0.104	p=0.195